Search the Newsreel

Quest Diagnostics Stock Gains As Oncology Moves Impress Wall Street

Quest Diagnostics (DGX) shares rose by 7.52% following strong earnings and increased full-year guidance, driven significantly by advancements in its oncology division. The New York State Department of Health's clearance of Quest's Haystack MRD ctDNA liquid biopsy test for minimal residual disease detection, enabling …

FEIM Secures $18 Million in New Aerospace Contract Awards

Frequency Electronics, Inc. (FEIM) has announced new aerospace contract awards totaling $18 million. This includes an $11 million contract for precision frequency-generation systems for a proliferated satellite program and an additional $7 million in follow-on production contracts. These awards are expected to strengthen FEIM's …

Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursd

Several large-cap stocks, including Lockheed Martin, Quest Diagnostics, and Thermo Fisher Scientific, are experiencing significant gains on Thursday after reporting better-than-expected quarterly financial results and, in many cases, raising their full-year guidance. Lockheed Martin reported strong earnings and sales, leading to an 11.4% jump …

Quest Diagnostics Surges After Hims- And Oura-Tied Beat

Quest Diagnostics put up a definitive beat Thursday, driven by solid demand across its consumer division, leading the stock to surge. Continue Reading

Frequency Electronics (FEIM) Q4 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, July 15, 2026, at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Thomas McClellandChief Financial Officer - Steven Bernstein TAKEAWAYS Funded Backlog -- $111 million at fiscal year-end, representing 59% annual growth and 34% …

Quest Diagnostics stock hits all-time high at 227.31 USD By Investing.com

Quest Diagnostics (DGX) stock achieved an all-time high of $227.31, with shares currently trading at $232, reflecting a 22.07% increase over the past year. The company has consistently raised its dividend for 14 consecutive years and recently surpassed analyst expectations for its second-quarter results …

DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised

Quest Diagnostics (DGX) reported a notable beat on both Q2 2026 earnings and revenue, with adjusted earnings per share up 19.1% year over year and revenues rising 10.2%. This strong performance, driven by increased testing demand, led the company to raise its full-year 2026 …

Frequency Electronics wins $18 million in satellite contracts By Investing.com

Frequency Electronics Inc. (NASDAQ:FEIM) announced it has secured approximately $18 million in new contracts for precision timing and frequency control products for satellite programs. This includes an $11 million award for a proliferated satellite program and $7 million in follow-on production contracts. The company …

Frequency Electronics (FEIM) Secures $18 Million in New Contracts

Frequency Electronics Inc. (FEIM) has secured new contracts totaling approximately $18 million, including an $11 million agreement for a precision frequency-generation system for a proliferated satellite initiative and $7 million in production contracts for space oscillators and other government programs. The company, a leader …

Quest Diagnostics Releases Q2 2026 Financial Results

Quest Diagnostics Incorporated exceeded Wall Street expectations for its second-quarter 2026 results, reporting adjusted earnings of $3.12 per share against an estimated $2.85, and revenue of $3.04 billion, a 10.2% increase from Q2 2025. The company benefited from strong demand for laboratory services and …

Quest Diagnostics raises full-year guidance after Q2 revenue rises 10.2%

Quest Diagnostics reported strong Q2 2026 financial results, with net revenue increasing by 10.2% to $3.043 billion and adjusted diluted EPS rising 19.1% to $3.12, both surpassing analyst estimates. Attributing the growth to execution across various channels and sustained demand, the company raised its …

Frequency Electronics Wins First $11M Satellite Contract From New Customer

Frequency Electronics (NASDAQ: FEIM) announced approximately $18 million in new contract awards, including an $11 million contract from a major aerospace prime contractor for a proliferated satellite program, marking their first contract with this new customer. The company also secured $7 million in follow-on …

Earnings Flash (DGX) Quest Diagnostics Incorporated Reports Q2 Revenue $3.04B, vs. FactSet Est of $2.97B

Quest Diagnostics Incorporated (DGX) reported Q2 revenue of $3.04 billion, surpassing FactSet's estimate of $2.97 billion. This financial news indicates a stronger-than-expected performance for the diagnostic testing and information services provider in the second quarter of 2026. Earlier, the company also announced Q2 adjusted …

Earnings Flash (DGX) Quest Diagnostics Incorporated Posts Q2 Adjusted EPS $3.12 per Share, vs. FactSet Est of $2.82

Quest Diagnostics Incorporated (DGX) reported Q2 adjusted EPS of $3.12 per share, exceeding the FactSet estimate of $2.82. The company also announced Q2 revenue of $3.04 billion, surpassing FactSet's estimate of $2.97 billion, and expects full-year 2026 revenue between $11.95 billion and $12.05 billion.

Quest Diagnostics stock rises 5% on strong Q2 beat, raised guidance

Quest Diagnostics (NYSE:DGX) reported strong second-quarter results, surpassing analyst expectations for both EPS and revenue. The company also raised its full-year 2026 guidance for both revenue and adjusted EPS, leading to a nearly 5% rise in pre-market trading. This performance was attributed to robust …

Quest Diagnostics climbs as Q2 earnings top estimates, guidance raised (DGX:NYSE)

Quest Diagnostics (DGX) shares rose by approximately 11% after the company announced second-quarter earnings that exceeded Wall Street's expectations. The diagnostic testing company also raised its full-year 2026 guidance above consensus. Adjusted earnings per share for the quarter were reported at $3.12, surpassing estimates.

QUEST DIAGNOSTICS ($DGX) Releases Q2 2026 Earnings | DGX Stock News

The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants

Quest Diagnostics Q2 Earnings Call Highlights

Quest Diagnostics Incorporated Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Revenue …

QUEST DIAGNOSTICS ($DGX) Releases Q2 2026 Earnings

Quest Diagnostics Earnings: Strong Quarterly Results Spur Optimistic Outlook for Second Half

What's Going On With Questerre Energy Corporation Stock Thursday?

Alice Queen Limited Issues Final Notice as 572.6 Million AQXOC Options Approach August 2026 Expiry

Quest’s (NYSE:DGX) Q2 CY2026: Beats On Revenue, Stock Soars

Quest's (NYSE:DGX) Q2 CY2026: Beats On Revenue, Stock Soars Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 10.2% year on year to $3.04 billion. Its non-GAAP profit of $3.12 per share was 10.5% above analysts' …

Frequency Electronics Inc (FEIM) Shares Fall 9.3% -- What GF Sco

Frequency Electronics Inc (FEIM) shares dropped 9.3% to $72.42, despite a 185.1% gain over the past year. GuruFocus's GF Value™ suggests the stock is 349.0% overvalued, with a GF Score™ of 59/100 indicating average performance but significant valuation concerns. The absence of insider transactions …

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aquestive Therapeutics, Inc. (AQST) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Aquestive Therapeutics, Inc. (NASDAQ:AQST) regarding potential corporate wrongdoing by its officers and/or directors. The firm is encouraging shareholders who purchased Aquestive securities prior to June 16, 2025, and continue to hold them, to contact …

Frequency Electronics, Inc. Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Frequency Electronics, Inc. (NASDAQ:FEIM) saw its share price jump 35% after reporting annual results, despite a surprise statutory loss of US$0.09 per share and revenues missing analyst predictions. Analysts are now more optimistic about the company's future, upgrading earnings per share estimates and increasing …

Quest Diagnostics earnings on deck as testing growth accelerates

Quest Diagnostics is set to report second-quarter earnings, with analysts expecting continued revenue and EPS growth. Investors will focus on the company's advanced diagnostics investments, routine testing demand, and use of AI to improve margins, as well as management's full-year outlook. The diagnostic testing …

Quest Diagnostics stock trades steadily as recent earnings and data volumes shape outlook

Quest Diagnostics (DGX) stock performance remains steady, supported by stable revenue growth and modest EPS expansion. The company reported $2.37 billion in revenue and $2.05 diluted EPS in a recent quarter, reflecting operational efficiency despite modest 1.7% revenue growth. With a market capitalization around …

FREQUENCY ELECTRONICS INC SEC Filing (Jul 22, 2026)

This article reports on an SEC filing (Form S-3) by FREQUENCY ELECTRONICS INC (FEIM) that became effective on July 21, 2026, at 5:00 P.M. The filing was accepted by SEC EDGAR on July 22, 2026, and is analyzed as having a neutral impact and …

Quest Diagnostics Rallies Ahead of Earnings as Investors Weigh Growth Initiatives | DGX Stock News

Quest Diagnostics Rallies Ahead of Earnings as Investors Weigh Growth Initiatives

Quess Corp To Hold Q1 Earnings Call Post July 29 Board Meeting

FEIM Stock Up 13% Despite Incurring Q4 Loss Due to Restructuring Costs

Frequency Electronics, Inc. (FEIM) stock rose 13% despite the company reporting a net loss of 50 cents per share in Q4 fiscal 2026 due to restructuring costs and investments. The company's funded backlog, however, reached a record $111 million, indicating strong future revenue visibility. …

Quest Diagnostics stock trades steadily as investors weigh recent revenue growth and dividend income

Quest Diagnostics stock reflects steady fundamentals, with investors focusing on recent revenue trends, earnings resilience, and cash returns via dividends alongside the broader US healthcare diagnostics sector. The company's financials show moderate revenue growth, stable earnings, and a consistent dividend payout, making it a …

DGX4807226 Bond Coupon Profile — Rate & Payments

This article provides the coupon profile for the DGX4807226 bond issued by Quest Diagnostics Incorporated. It details that the current coupon rate is 4.20% and the next payment is scheduled for December 31, 2026. The article highlights the bond's interest payment overview and offers …